In honor of Myeloma Action Month, Amgen spoke with the International Myeloma Foundation’s (IMF) Chief Medical Officer Dr. Joseph Mikhael to uncover the latest insights on myeloma care, cutting-edge therapies, and the urgent need to address disparities in diagnosis and treatment.

Dr. Mikhael talks about how the M-Power Initiative is working to close the gap in healthcare access for African American and Hispanic/Latino American communities. He also discusses the latest immune-based treatments that are transforming patient outcomes.

The article also provides steps for readers to take action this Myeloma Action Month to join the #MyelomaMilestone movement. Read the full article now from the button below.